The Board of Directors of Gufic Biosciences Limited, in their meeting held on May 29, 2026, approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The company reported a standalone revenue from operations of 25,205.23 Lakhs for the quarter ended March 31, 2026, compared to 23,109.36 Lakhs in the previous quarter and 20,502.01 Lakhs in the corresponding quarter of the previous year. The net profit for the period stood at 2,057.44 Lakhs, reflecting an increase from 1,556.39 Lakhs in the previous quarter and 797.41 Lakhs in the same quarter last year.
| Particulars | Quarter Ended 31-Mar-26 (Lakhs) | QoQ Change (%) | YoY Change (%) |
|---|---|---|---|
| Revenue from Operations | 25,205.23 | 9.07% | 22.94% |
| Net Profit | 2,057.44 | 32.20% | 158.02% |
Gufic Biosciences Limited is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical products.
Leave a Reply